‘Can we talk about RFK Jr.?’ Inside the chill sweeping vaccine makers

“There’s a profound amount of disease that’s generated in primary schoolchildren as they congregate,” Grant Pickering, the vaccine-maker’s CEO, said at an investment conference in June. Less than two months later, Vaxcyte announced that it would hold off starting human trials for its strep vaccine,...

Redirecting to full article...